← Leaderboards
Ira J. Fox
University Of Nebraska Medical Center
$16,510,315
Attributed
$21,664,322
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$21,664,322 · 9
By mechanism
R01$16,484,390 · 6
P01$4,734,394 · 2
R56$445,538 · 1
Top collaborators
- Jeffrey L Platt5 shared
- Joseph Locker Locker4 shared
- Gerard Vockley4 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Larisa Y Poluektova$9,010,153
- Channabasavaiah Gurumurthy$4,156,685
- William H Gmeiner$6,919,412
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverHepatocyteCellsImmuneLiver DiseasesTransplantationLiver FailureHepaticLiver FunctionPhenotypeLiver TransplantationBaseIn VivoAdultCirrhosisAnimalsMetabolicChronicLiver InjuryCell LineLeadIn VitroGenesCharacteristics
Grant awards (45)
Models of AT Deficiency Using Human Hepatocytes$604,721
P01 · FY2023 · DK · contact PI
Models of AT Deficiency Using Human Hepatocytes$610,272
P01 · FY2022 · DK · contact PI
Hepatocyte Transplantation for Liver Based Metabolic Disease$1
R01 · FY2022 · DK · contact PI
Models of AT Deficiency Using Human Hepatocytes$615,644
P01 · FY2021 · DK · contact PI
Hepatocyte xenografts for treatment of acute liver failure$1,001,746
R01 · FY2020 · AI · contact PI
Hepatocyte Transplantation for Liver Based Metabolic Disease$958,429
R01 · FY2020 · DK · contact PI
Models of AT Deficiency Using Human Hepatocytes$620,929
P01 · FY2020 · DK · contact PI
Hepatocyte xenografts for treatment of acute liver failure$1,006,195
R01 · FY2019 · AI · contact PI
Hepatocyte Transplantation for Liver Based Metabolic Disease$958,429
R01 · FY2019 · DK · contact PI
Models of AT Deficiency Using Human Hepatocytes$630,750
P01 · FY2019 · DK · contact PI
Hepatocyte xenografts for treatment of acute liver failure$1,004,804
R01 · FY2018 · AI · contact PI
Hepatocyte Transplantation for Liver Based Metabolic Disease$965,154
R01 · FY2018 · DK · contact PI
Hepatocyte xenografts for treatment of acute liver failure$998,829
R01 · FY2017 · AI · contact PI
Hepatocyte xenografts for treatment of acute liver failure$1,034,028
R01 · FY2016 · AI · contact PI
Regulation of HNF4 in Hepatic Failure in Cirrhosis$595,100
R01 · FY2016 · DK · contact PI
Regulation of HNF4 in Hepatic Failure in Cirrhosis$595,100
R01 · FY2015 · DK · contact PI
Humanized mouse models of AT Deficiency$459,234
P01 · FY2015 · DK · contact PI
Regulation of HNF4 in Hepatic Failure in Cirrhosis$595,100
R01 · FY2014 · DK · contact PI
Humanized mouse models of AT Deficiency$462,469
P01 · FY2014 · DK · contact PI
Regulation of HNF4 in Hepatic Failure in Cirrhosis$595,100
R01 · FY2013 · DK · contact PI
Humanized mouse models of AT Deficiency$459,797
P01 · FY2013 · DK · contact PI
Humanized mouse models of AT Deficiency$270,578
P01 · FY2012 · DK · contact PI
Xenogeneic Hepatocyte Transplantation$445,538
R56 · FY2010 · AI · contact PI
Cellular Engineering of Hepatocyte Cell Lines$362,357
R01 · FY2010 · DK · contact PI
Cellular Engineering of Hepatocyte Cell Lines$355,907
R01 · FY2009 · DK · contact PI
Xenogeneic Hepatocyte Transplantation for Cirrhosis$46,365
R01 · FY2009 · AI · contact PI
Cellular Engineering of Hepatocyte Cell Lines$346,164
R01 · FY2008 · DK · contact PI
Cellular Engineering of Hepatocyte Cell Lines$332,102
R01 · FY2007 · DK · contact PI
Xenogeneic Hepatocyte Transplantation for Cirrhosis$258,109
R01 · FY2007 · AI · contact PI
Xenogeneic Hepatocyte Transplantation for Cirrhosis$225,001
R01 · FY2007 · AI · contact PI
Xenogeneic Hepatocyte Transplantation for Cirrhosis$486,248
R01 · FY2006 · AI · contact PI
Cellular Engineering of Hepatocyte Cell Lines$279,340
R01 · FY2006 · DK · contact PI
Xenogeneic Hepatocyte Transplantation for Cirrhosis$486,722
R01 · FY2005 · AI
Cellular Engineering of Hepatocyte Cell Lines$286,062
R01 · FY2005 · DK
Xenogeneic Hepatocyte Transplantation for Cirrhosis$475,688
R01 · FY2004 · AI
Cellular Engineering of Hepatocyte Cell Lines$286,062
R01 · FY2004 · DK
Cellular Engineering of Hepatocyte Cell Lines$36,750
R01 · FY2004 · DK
Cellular Engineering of Hepatocyte Cell Lines$288,569
R01 · FY2003 · DK
Xenogeneic Hepatocyte Transplantation for Cirrhosis$223,569
R01 · FY2003 · AI
Cellular Engineering of Hepatocyte Cell Lines$36,750
R01 · FY2003 · DK
GENE THERAPY IN INDUCTION OF TRANSPLANT TOLERANCE$296,425
R01 · FY2002 · AI
Cellular Engineering of Hepatocyte Cell Lines$294,584
R01 · FY2002 · DK
GENE THERAPY IN INDUCTION OF TRANSPLANT TOLERANCE$289,465
R01 · FY2001 · AI
GENE THERAPY IN INDUCTION OF TRANSPLANT TOLERANCE$281,070
R01 · FY2000 · AI
CELLULAR ENGINEERING OF HEPATOCYTE CELL LINES$203,066
R01 · FY2000 · DK